ArticleFrontiers in dementia2025
Sarcopenia and cognitive performance in hospitalized older adults: evidence of an association.
Article in Frontiers in dementia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Muscle Function Deficit Concept and Inflammaging.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Population aging increases the coexistence of geriatric syndromes, including sarcopenia and cognitive impairment, which negatively affect functional prognosis and clinical outcomes. Evidence on the association between sarcopenia and cognitive performance in hospitalized elderly individuals, particularly across cognitive domains, remains limited. Therefore, the objective of this study was to investigate the association between sarcopenia and cognitive performance, both globally and across specific cognitive domains, in hospitalized elderly individuals. Methods: This observational cross-sectional study included elderly patients hospitalized in a medium-sized hospital in São Paulo, Brazil, from 2024 to 2025, evaluated within the first 48 hours of admission. Exclusion criteria included weight-loss diets, chronic renal failure on dialysis, paresis or hemiparesis due to stroke, altered body fluid levels, pacemaker use, and chronic corticosteroid therapy. Sarcopenia screening and diagnosis followed the European Consensus criteria, and cognitive performance was assessed using the Mini-Mental State Examination (MMSE). Comparative analyses were conducted among non-sarcopenic, sarcopenia risk, and sarcopenic groups, including correlations with sociodemographic variables. Results: Eighty-four older adults were assessed (54.76% women; mean age 68.1 ± 6.7 years). Sarcopenia risk was identified in 29.76% and confirmed sarcopenia in 19.05%. MMSE scores showed a moderate negative correlation with age ( Conclusion: Sarcopenia, even at early stages, is associated with reduced global cognitive performance and specific impairments in orientation, attention/calculation, and language in hospitalized elderly individuals. These findings underscore the importance of early screening and targeted interventions to preserve both muscle and cognitive health, reinforcing the need for integrated care strategies in hospital settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.